Conversely, miR-345 showed low expression in HCC, counteracting the inhibitory impact of IRF1 through reversible trans-overexpression, thereby influencing the epithelial-mesenchymal transition process and tumor metastasis [101]. The gene discussed is IRF1; the disease is neoplasm.